The spliceosome as target for anticancer treatment
2009
The spliceosome as a target for anticancer treatment
publication
Evidence: moderate
Author Information
Author(s): van Alphen R J, Wiemer E A C, Burger H, Eskens F A L M
Primary Institution: Erasmus University Medical Centre
Hypothesis
Can targeting the spliceosome provide a novel approach for anticancer drug development?
Conclusion
Targeting the spliceosome with specific compounds shows promise as a new strategy for cancer treatment.
Supporting Evidence
- Recent discoveries show that the spliceosome can be targeted by natural compounds with anticancer activity.
- Two compounds, pladienolide and spliceostatin A, have been identified as effective in inhibiting cancer cell growth.
- Targeting the spliceosome may lead to new therapeutic strategies for various cancers.
Takeaway
Scientists are looking at a part of our cells called the spliceosome to find new ways to treat cancer. By blocking it, they hope to stop cancer cells from growing.
Methodology
The review discusses various compounds that target the spliceosome and their effects on cancer cells.
Limitations
The review is based on existing literature and does not present new experimental data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website